Search Results

Filter
  • 1-10 of  1,449 results for ""Deferoxamine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy.

  • Authors : Lei L; Department of Chemistry, Engineering Research Center for Molecular Medicine, College of Basic Medical Science, Guizhou Medical University, Guiyang, 550025, China.; Department of Neurosurgery, the Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism

  • Source: Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2024 Oct; Vol. 36 (41), pp. e2409329. Date of Electronic Publication: 2024 Sep 02.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 9885358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4095

Record details

×
Academic Journal

Unlocking the potential of deferoxamine: a systematic review on its efficacy and safety in alleviating myocardial ischemia-reperfusion injury in adult patients following cardiopulmonary bypass compared to standard care.

Subjects: Cardiopulmonary Bypass*/Cardiopulmonary Bypass*/Cardiopulmonary Bypass*/adverse effects ; Deferoxamine*/Deferoxamine*/Deferoxamine*/administration & dosage ; Deferoxamine*/Deferoxamine*/Deferoxamine*/adverse effects

  • Source: Therapeutic advances in cardiovascular disease [Ther Adv Cardiovasc Dis] 2024 Jan-Dec; Vol. 18, pp. 17539447241277382.Publisher: Sage Publications Country of Publication: England NLM ID: 101316343 Publication Model: Print Cited Medium: Internet ISSN: 1753-9455

Record details

×
Academic Journal

Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism.

  • Authors : Chen C; School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200000, China. .; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200000, China. .

Subjects: Deferoxamine/Deferoxamine/Deferoxamine/*pharmacology ; Iron/Iron/Iron/*metabolism ; Mitochondria/Mitochondria/Mitochondria/*drug effects

  • Source: International journal of molecular sciences [Int J Mol Sci] 2019 Oct 08; Vol. 20 (19). Date of Electronic Publication: 2019 Oct 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Deferoxamine preconditioning ameliorates mechanical ventilation-induced lung injury in rat model via ROS in alveolar macrophages: a randomized controlled study.

  • Authors : Zhu W; Department of Anesthesia, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, China. .; Huang Y

Subjects: Deferoxamine/Deferoxamine/Deferoxamine/*pharmacology ; Lung/Lung/Lung/*pathology ; Macrophages, Alveolar/Macrophages, Alveolar/Macrophages, Alveolar/*metabolism

  • Source: BMC anesthesiology [BMC Anesthesiol] 2018 Aug 18; Vol. 18 (1), pp. 116. Date of Electronic Publication: 2018 Aug 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100968535 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2253

Record details

×
Academic Journal

Deferoxamine-Induced Migration and Odontoblast Differentiation via ROS-Dependent Autophagy in Dental Pulp Stem Cells.

Subjects: Autophagy/Autophagy/Autophagy/*drug effects ; Cell Differentiation/Cell Differentiation/Cell Differentiation/*drug effects ; Deferoxamine/Deferoxamine/Deferoxamine/*pharmacology

  • Source: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology [Cell Physiol Biochem] 2017; Vol. 43 (6), pp. 2535-2547. Publisher: Cell Physiol Biochem Press GmbH & Co KG Country of Publication: Germany NLM ID: 9113221 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Deferoxamine promotes MDA-MB-231 cell migration and invasion through increased ROS-dependent HIF-1α accumulation.

  • Authors : Liu Y; Center of Hygiene Assessment and Research, Institute of Disease Control and Prevention, Academy of Military Medical Sciences, Beijing, China.; Cui Y

Subjects: Cell Movement/Cell Movement/Cell Movement/*drug effects ; Deferoxamine/Deferoxamine/Deferoxamine/*toxicity ; Hypoxia-Inducible Factor 1, alpha Subunit/Hypoxia-Inducible Factor 1, alpha Subunit/Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism

  • Source: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology [Cell Physiol Biochem] 2014; Vol. 33 (4), pp. 1036-46. Publisher: Cell Physiol Biochem Press GmbH & Co KG Country of Publication: Germany NLM ID: 9113221 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Iron complexation with oral deferoxamine in a swine model.

  • Authors : Dean BS; Children's Hospital of Pittsburgh, PA 15213, USA.; Oehme FW

Subjects: Antidotes/Antidotes/Antidotes/*therapeutic use ; Deferoxamine/Deferoxamine/Deferoxamine/*therapeutic use ; Ferrous Compounds/Ferrous Compounds/Ferrous Compounds/*poisoning

  • Source: Veterinary and human toxicology [Vet Hum Toxicol] 1996 Apr; Vol. 38 (2), pp. 96-8.Publisher: American College of Veterinary Toxicologists Country of Publication: United States NLM ID: 7704194 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

ROS-triggered degradable iron-chelating nanogels: Safely improving iron elimination in vivo.

  • Authors : Liu Z; Department of Pharmaceutical & Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602-2352, USA.; Qiao J

Subjects: Deferoxamine/Deferoxamine/Deferoxamine/*administration & dosage ; Iron/Iron/Iron/*metabolism ; Iron Chelating Agents/Iron Chelating Agents/Iron Chelating Agents/*administration & dosage

  • Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2018 Aug 10; Vol. 283, pp. 84-93. Date of Electronic Publication: 2018 May Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Synthesis and characterization of superoxide dismutase-deferoxamine conjugate via polyoxyethylene: a new molecular device for removal of a variety of reactive oxygen species.

  • Authors : Sato H; Central Research Laboratories, Ajinomoto Company, Inc, Kawasaki, Japan.; Watanabe M

Subjects: Free Radical Scavengers*; Deferoxamine/Deferoxamine/Deferoxamine/*chemistry ; Polyethylene Glycols/Polyethylene Glycols/Polyethylene Glycols/*chemistry

  • Source: Bioconjugate chemistry [Bioconjug Chem] 1995 May-Jun; Vol. 6 (3), pp. 249-54.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9010319 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Dual effect of deferoxamine on free radical formation and reoxygenation injury in isolated hepatocytes.

  • Authors : Caraceni P; Department of Physiology and Surgery, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.; Van Thiel DH

Subjects: Deferoxamine/Deferoxamine/Deferoxamine/*pharmacology ; Liver/Liver/Liver/*drug effects ; Oxygen/Oxygen/Oxygen/*pharmacology

  • Source: The American journal of physiology [Am J Physiol] 1995 Jul; Vol. 269 (1 Pt 1), pp. G132-7.Publisher: American Physiological Society Country of Publication: United States NLM ID: 0370511 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  1,449 results for ""Deferoxamine""